ConductScience.org, home

Paper36088407

Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections.

Sadyrbaeva-Dolgova S and 5 others. Sci Rep, 2022. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections. Papers, record 36088407. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36088407

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections.
PubMed
Journal
Sci Rep
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.95
iCite
Revised in PubMed
2025-07-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sadyrbaeva-Dolgova SSvetlana
2García-Fumero RRicardo
3Exposito-Ruiz MManuela
4Pasquau-Liaño JJuan
5Jiménez-Morales AAlberto
6Hidalgo-Tenorio CCarmen

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gram-Negative Bacterial InfectionsMajor topic
Renal InsufficiencyMajor topic
Colistin
Creatinine
Humans
Incidence
Pseudomonas aeruginosa
Retrospective Studies

Source PubMed

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129,444,952Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.Clin Microbiol Rev2018https://conductscience.org/library/papers/29444952PubMed
225,756,417Association between colistin dose and development of nephrotoxicity.Crit Care Med2015https://conductscience.org/library/papers/25756417PubMed
329,456,043Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.Lancet Infect Dis2018https://conductscience.org/library/papers/29456043PubMed
431,923,573Is colistin-associated acute kidney injury clinically important in adults? A systematic review and meta-analysis.Int J Antimicrob Agents2020https://conductscience.org/library/papers/31923573PubMed
522,890,468KDIGO clinical practice guidelines for acute kidney injury.Nephron Clin Pract2012https://conductscience.org/library/papers/22890468PubMed
616,940,086Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.Antimicrob Agents Chemother2006https://conductscience.org/library/papers/16940086PubMed
715,825,037Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.Clin Infect Dis2005https://conductscience.org/library/papers/15825037PubMed
830,710,469
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).
Pharmacotherapy2019https://conductscience.org/library/papers/30710469PubMed
922,423,120High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.Clin Infect Dis2012https://conductscience.org/library/papers/22423120PubMed
1030,323,035New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/30323035PubMed
1116,280,245Nephrotoxicity of intravenous colistin: a prospective evaluation.Int J Antimicrob Agents2005https://conductscience.org/library/papers/16280245PubMed
1223,357,291Tigecycline: an update.Diagn Microbiol Infect Dis2013https://conductscience.org/library/papers/23357291PubMed
1319,303,668[Aminoglycosides and polymyxins].Enferm Infecc Microbiol Clin2009https://conductscience.org/library/papers/19303668PubMed
1420,302,384Self-assembly behavior of colistin and its prodrug colistin methanesulfonate: implications for solution stability and solubilization.J Phys Chem B2010https://conductscience.org/library/papers/20302384PubMed
1520,045,293Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.Int J Antimicrob Agents2010https://conductscience.org/library/papers/20045293PubMed
1628,011,614Dosing guidance for intravenous colistin in critically-ill patients.Clin Infect Dis2017https://conductscience.org/library/papers/28011614PubMed
1727,624,572Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis.J Antimicrob Chemother2017https://conductscience.org/library/papers/27624572PubMed
1823,357,775Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23357775PubMed
1919,433,570Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19433570PubMed
2028,970,161The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.Clin Microbiol Infect2018https://conductscience.org/library/papers/28970161PubMed

See all 29 references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42,792,016Predictors of In-Hospital Mortality Among Hospitalized Colistin-Treated Patients at a Tertiary Urology-Nephrology Referral Center.Antibiotics (Basel)2026https://conductscience.org/library/papers/42792016PubMed
42,183,845Synergistic strategies to rescue the last-resort antibiotic colistin.Arch Microbiol2026https://conductscience.org/library/papers/42183845PubMed
41,704,330Efficacy of inhaled antibiotics in children with ventilator-associated pneumonia: A systematic review and meta-analysis.J Crit Care Med (Targu Mures)2026https://conductscience.org/library/papers/41704330PubMed
41,007,816Antimicrobial Resistance of Non-Fermenting Gram-Negative Bacilli in a Multidisciplinary Hospital in Romania.Biomedicines2025https://conductscience.org/library/papers/41007816PubMed
40,880,630Colistimethate sodium is efficacious and safe for the management of sepsis in hematological diseases patients: a retrospective study in China.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/40880630PubMed
40,787,933Drug-resistant Acinetobacter baumannii: mortality, emerging treatments, and future pharmacological targets for a WHO priority pathogen.Clin Microbiol Rev2025https://conductscience.org/library/papers/40787933PubMed
40,781,278Acute kidney injury of intravenous colistin sulfate compared with colistimethate sodium: a real-world, retrospective cohort study.BMC Infect Dis2025https://conductscience.org/library/papers/40781278PubMed
37,110,322The Challenge of Bacteremia Treatment due to Non-Fermenting Gram-Negative Bacteria.Microorganisms2023https://conductscience.org/library/papers/37110322PubMed

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213

Source NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36088407

GET https://conductscience.org/api/papers/v1/36088407/references?page=2